Could a simple implant spare men from urinary pain after prostate radiation?

NCT ID NCT05148156

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether placing a Urolift device in the prostate before stereotactic body radiation therapy (SBRT) can reduce urinary side effects like frequent urination, pain, and nighttime trips to the bathroom. About 20 men with both prostate cancer and benign prostatic hyperplasia (BPH) will receive the Urolift and then SBRT. Researchers will track symptom scores and quality of life for one year to see if the device helps.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Urolift device

What this could lead to

If it works, this could offer a way to reduce urinary problems after prostate radiation, improving quality of life for men with BPH.

What could go wrong

This is a very small, early study (20 people) that is currently suspended. It may not show a clear benefit, and results may not apply to all patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

benign prostatic hyperplasia Dysuria Nocturia prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Northwell Health

    Syosset, New York, 11791, United States